These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 27881256)

  • 1. Cost-Effectiveness Analysis of the Self-Management Program for Thai Patients with Metabolic Syndrome.
    Sakulsupsiri A; Sakthong P; Winit-Watjana W
    Value Health Reg Issues; 2016 May; 9():28-35. PubMed ID: 27881256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients.
    Phisalprapa P; Supakankunti S; Charatcharoenwitthaya P; Apisarnthanarak P; Charoensak A; Washirasaksiri C; Srivanichakorn W; Chaiyakunapruk N
    Medicine (Baltimore); 2017 Apr; 96(17):e6585. PubMed ID: 28445256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand.
    Permsuwan U; Chaiyakunapruk N; Dilokthornsakul P; Thavorn K; Saokaew S
    Appl Health Econ Health Policy; 2016 Jun; 14(3):281-92. PubMed ID: 26961276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Utility of Video-Electroencephalography Monitoring Followed by Surgery in Adults with Drug-Resistant Focal Epilepsy in Thailand.
    Kitwitee P; Unnwongse K; Srikijvilaikul T; Yadee T; Limwattananon C
    World Neurosurg; 2017 Feb; 98():750-760.e3. PubMed ID: 27913266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analysis of intravenous immunoglobulin for the treatment of steroid-refractory dermatomyositis in Thailand.
    Bamrungsawad N; Chaiyakunapruk N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P
    Pharmacoeconomics; 2015 May; 33(5):521-31. PubMed ID: 25774016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis.
    Kingkaew P; Maleewong U; Ngarmukos C; Teerawattananon Y
    Value Health; 2012; 15(1 Suppl):S20-8. PubMed ID: 22265062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
    Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
    J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
    Lam SW; Wai M; Lau JE; McNamara M; Earl M; Udeh B
    Pharmacotherapy; 2017 Jan; 37(1):94-103. PubMed ID: 27870079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
    Teerawattananon Y; Mugford M; Tangcharoensathien V
    Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand.
    Chongmelaxme B; Phisalprapa P; Sawangjit R; Dilokthornsakul P; Chaiyakunapruk N
    Pharmacoeconomics; 2019 Feb; 37(2):267-278. PubMed ID: 30430467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of the screening program for early oral cancer detection in Thailand.
    Kumdee C; Kulpeng W; Teerawattananon Y
    PLoS One; 2018; 13(11):e0207442. PubMed ID: 30496214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of diabetes self-management programs in community primary care settings.
    Brownson CA; Hoerger TJ; Fisher EB; Kilpatrick KE
    Diabetes Educ; 2009; 35(5):761-9. PubMed ID: 19622716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
    Findley LJ; Lees A; Apajasalo M; Pitkänen A; Turunen H
    Curr Med Res Opin; 2005 Jul; 21(7):1005-14. PubMed ID: 16004667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand.
    Saokaew S; Permsuwan U; Chaiyakunapruk N; Nathisuwan S; Sukonthasarn A; Jeanpeerapong N
    Thromb Res; 2013 Oct; 132(4):437-43. PubMed ID: 24041634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation.
    Kantito S; Saokaew S; Yamwong S; Vathesatogkit P; Katekao W; Sritara P; Chaiyakunapruk N
    J Thromb Thrombolysis; 2018 Feb; 45(2):281-290. PubMed ID: 29181693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of ticagrelor and generic clopidogrel in patients with acute coronary syndrome in Switzerland.
    Gasche D; Ulle T; Meier B; Greiner RA
    Swiss Med Wkly; 2013; 143():w13851. PubMed ID: 24089294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness Analysis of Renin-Angiotensin Aldosterone System Blockade in Progression of Chronic Kidney Disease.
    Pattanaprateep O; Ingsathit A; McEvoy M; Attia J; Thakkinstian A
    Value Health Reg Issues; 2018 May; 15():155-160. PubMed ID: 29730248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand.
    Permsuwan U; Dilokthornsakul P; Thavorn K; Saokaew S; Chaiyakunapruk N
    J Med Econ; 2017 Feb; 20(2):171-181. PubMed ID: 27645706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.
    Stollenwerk B; Bartmus T; Klug F; Stock S; Müller D
    Osteoporos Int; 2015 Apr; 26(4):1367-79. PubMed ID: 25572047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of the Hepatitis C Self-Management Program.
    Groessl EJ; Sklar M; Laurent DD; Lorig K; Ganiats TG; Ho SB
    Health Educ Behav; 2017 Feb; 44(1):113-122. PubMed ID: 27206463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.